[ET Net News Agency, 1 September 2026] HANSOH PHARMA (03692) fell 3.1% to HK$34.26.
It hits an intra-day low of HK$34.26, and an intra-day high of HK$35.68. The total shares traded was 3.9 million, with a value of HK$135.68m. The active buy/sell ratio is 52:48, with net buying turnover of HK$3.76m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$4.01m, with volume weighted average price of HK$34.688. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$10.73m, with volume weighted average price of HK$34.766. The stock has fallen a combined 7% over the past 3 consecutive trading days.
The Hang Seng Index now fell 312 points, or 1.2% to 25,254; the Hang Seng China Enterprises Index now fell 76 points, or 0.9% to 8,436.
Basic Information| Nominal | 34.260 | % Chg | -3.06% |
| High | 35.680 | Low | 34.260 |
| Shares Tr | 3.9m | Turnover | 135.68m |
| 10-D SMA | 33.726 | %H.V | 66.319 |
| 20-D SMA | 33.456 | VWAP | 34.784 |
| 50-D SMA | 32.452 | RSI14 | 53.832 |
Status: Active buy/sell ratio is 52:48, with net buying turnover of HK$3.76m, falling a combined 7% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.260 | -3.06 |
| SIHUAN PHARM (00460) | 0.735 | -2.00 |
| GRAND PHARMA (00512) | 5.020 | Unchanged |
| SBP GROUP (01177) | 5.280 | -1.86 |
| HENGRUI PHARMA (01276) | 46.060 | Unchanged |
| LIVZON PHARMA (01513) | 19.990 | +0.55 |
| LUYE PHARMA (02186) | 1.890 | -2.58 |
| FOSUN PHARMA (02196) | 16.200 | +1.31 |
| SH PHARMA (02607) | 11.550 | +1.67 |
| CHINARES PHARMA (03320) | 4.450 | -0.45 |
(ed)
